• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

凝胶化过程中溶解时共无定形物新的增溶行为的研究:络合和抗结晶作用的重要性。

Study on co-amorphous emerging solubilization behavior after gelation during dissolution: The importance of complexation and anti-crystallization.

机构信息

School of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065, PR China; Research Center for Pharmaceutical Preparations, Hubei University of Chinese Medicine, Wuhan 430065, PR China.

School of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065, PR China; Research Center for Pharmaceutical Preparations, Hubei University of Chinese Medicine, Wuhan 430065, PR China; Hubei Shizhen Laboratory, Wuhan, 430065, PR China.

出版信息

Int J Pharm. 2024 Oct 25;664:124592. doi: 10.1016/j.ijpharm.2024.124592. Epub 2024 Aug 17.

DOI:10.1016/j.ijpharm.2024.124592
PMID:39159855
Abstract

Co-amorphous (CM) is a promising technology for enhancing the aqueous solubility of insoluble drugs, but the gelation phenomenon has often occurred during the dissolution process and seriously threatened their solubility/dissolution performance. Therefore, it's quite important to design favorable CM systems to alleviate or even avoid the adverse effects of gelation phenomenon. In this study, CM systems of taxifolin (TAX) and oxymatrine (OMT) (TAX-OMT CMs) were constructed to improve the solubility and dissolution properties of TAX. Interestingly, TAX-OMT CMs gradually aggregated and obviously gelled during dissolution, but the solubility and dissolution of TAX in TAX-OMT CMs were significantly enhanced compared to crystalline TAX. Consequently, the underlying solubilization mechanisms of TAX-OMT CMs after gelation were systematically explored. For one thing, the complexation between the two components in TAX-OMT CMs was verified by phase solubility, fluorescence spectroscopy and isothermal titration calorimetry. For another, the residual solids of TAX-OMT CMs after dissolution evaluation were thoroughly characterized by means of powder X-ray diffraction, fourier transform infrared spectroscopy, scanning electron microscopy, which showed the anti-crystallization property of TAX-OMT CMs. Furthermore, molecular simulation demonstrated the intermolecular interactions of TAX-OMT CMs alone and TAX-OMT complexes in aqueous solution. Finally, pharmacokinetics study in rats suggested that the bioavailability of TAX in TAX-OMT CM (1:2) was approximately 5.5-fold higher than that of crystalline TAX after oral administration. Collectively, this study reveals the importance of complexation and anti-crystallization effects of CM systems on maintaining solubilization behavior after gelation, providing an effective strategy to improve the absorption performance of pharmaceutical CM systems.

摘要

共无定形物(CM)是提高难溶性药物水溶解度的一种很有前途的技术,但在溶解过程中经常会出现凝胶现象,严重威胁其溶解度/溶解性能。因此,设计有利的 CM 系统以减轻甚至避免凝胶现象的不利影响是非常重要的。在这项研究中,构建了圣草酚(TAX)和氧化苦参碱(OMT)的 CM 系统(TAX-OMT CM)以提高 TAX 的溶解度和溶解性能。有趣的是,TAX-OMT CM 在溶解过程中逐渐聚集并明显胶凝,但 TAX 在 TAX-OMT CM 中的溶解度和溶解明显增强,与结晶 TAX 相比。因此,系统地探讨了 TAX-OMT CM 胶凝后的潜在增溶机制。一方面,通过相溶解度、荧光光谱和等温滴定量热法验证了 TAX-OMT CM 中两种成分的络合作用。另一方面,通过粉末 X 射线衍射、傅里叶变换红外光谱、扫描电子显微镜对 TAX-OMT CM 溶解评价后的残余固体进行了彻底表征,结果表明 TAX-OMT CM 具有抗结晶性。此外,分子模拟表明了 TAX-OMT CM 单独和 TAX-OMT 复合物在水溶液中的分子间相互作用。最后,大鼠药代动力学研究表明,口服 TAX-OMT CM(1:2)后 TAX 的生物利用度约为结晶 TAX 的 5.5 倍。综上所述,本研究揭示了 CM 系统的络合和抗结晶作用对胶凝后保持增溶行为的重要性,为提高药物 CM 系统的吸收性能提供了一种有效的策略。

相似文献

1
Study on co-amorphous emerging solubilization behavior after gelation during dissolution: The importance of complexation and anti-crystallization.凝胶化过程中溶解时共无定形物新的增溶行为的研究:络合和抗结晶作用的重要性。
Int J Pharm. 2024 Oct 25;664:124592. doi: 10.1016/j.ijpharm.2024.124592. Epub 2024 Aug 17.
2
Incorporation of Complexation into a Coamorphous System Dramatically Enhances Dissolution and Eliminates Gelation of Amorphous Lurasidone Hydrochloride.将络合作用纳入共无定形系统可显著提高无定形盐酸鲁拉西酮的溶解性能并消除其胶凝作用。
Mol Pharm. 2020 Jan 6;17(1):84-97. doi: 10.1021/acs.molpharmaceut.9b00772. Epub 2019 Dec 16.
3
Apigenin-oxymatrine binary co-amorphous mixture: Enhanced solubility, bioavailability, and anti-inflammatory effect.芹菜素-氧化苦参碱二元共无定形混合物:提高溶解度、生物利用度和抗炎作用。
Food Chem. 2022 Mar 30;373(Pt B):131485. doi: 10.1016/j.foodchem.2021.131485. Epub 2021 Oct 28.
4
Co-amorphous systems of sulfasalazine with matrine-type alkaloids: Enhanced solubility behaviors and synergistic therapeutic potential.柳氮磺胺吡啶与苦参型生物碱共无定形系统:增强的溶解行为和协同治疗潜力。
Eur J Pharm Biopharm. 2024 Oct;203:114475. doi: 10.1016/j.ejpb.2024.114475. Epub 2024 Aug 30.
5
Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.制备无定形呋塞米钠盐可提高溶解度和溶出速率,并导致大鼠口服给药后的 Tmax 更快。
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):942-51. doi: 10.1016/j.ejpb.2013.09.002. Epub 2013 Sep 27.
6
A phospholipid complex to improve the oral bioavailability of flavonoids.一种用于提高类黄酮口服生物利用度的磷脂复合物。
Drug Dev Ind Pharm. 2015;41(10):1693-703. doi: 10.3109/03639045.2014.991402. Epub 2014 Dec 11.
7
Complexation of Apigenin and Oxymatrine Leading to Enhanced Anti-inflammatory Activity.芹菜素和氧化苦参碱的络合导致抗炎活性增强。
J Nat Prod. 2023 May 26;86(5):1179-1188. doi: 10.1021/acs.jnatprod.2c00947. Epub 2023 Apr 28.
8
Process optimization, characterization and evaluation in vivo of oxymatrine-phospholipid complex.氧化苦参碱-磷脂复合物的体内过程优化、性质表征和评价。
Int J Pharm. 2010 Mar 15;387(1-2):139-46. doi: 10.1016/j.ijpharm.2009.12.008. Epub 2009 Dec 18.
9
Physicochemical and pharmacokinetic characterization of amorphous solid dispersion of tranilast with enhanced solubility in gastric fluid and improved oral bioavailability.曲尼司特无定形固体分散体的理化性质和药代动力学特征研究:提高了在胃液中的溶解度和口服生物利用度。
Drug Metab Pharmacokinet. 2012;27(4):379-87. doi: 10.2133/dmpk.dmpk-11-rg-101. Epub 2012 Jan 13.
10
Eplerenone nanocrystals engineered by controlled crystallization for enhanced oral bioavailability.采用控制结晶工程化技术的依普利酮纳米晶体,提高口服生物利用度。
Drug Deliv. 2021 Dec;28(1):2510-2524. doi: 10.1080/10717544.2021.2008051.

引用本文的文献

1
Recent Advances in Coamorphous Systems of Natural Active Pharmaceutical Ingredients: Preparations, Characterizations, and Applications.天然活性药物成分共无定形体系的研究进展:制备、表征及应用
ACS Omega. 2025 Aug 5;10(32):35352-35366. doi: 10.1021/acsomega.5c03834. eCollection 2025 Aug 19.